Thanks, Gaz. I like the Finkelstein sides. Better than placebo function seems to be the main issue in his mind when evaluating ATH434 and then the brain atrophy, even not statistically significant. He does not speak about iron content, maybe because myelin is a disturbing MRI measurement when 3Tesla MRI is used. See: https://www.nature.com/articles/s41398-024-02976-y
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $41.54K | 4.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 11136808 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4729475 | 10 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |